RESUMEN

A randomized double-blind study about the therapy of the cirrhosis of the liver shows a significant higher surviving rate of the alcoholic cirrhosis in the group treated with Silymarin. This result can be well explained by the protective influence of this substance against toxic injuries. The etiology of many chronic liver diseases is uncertain and therefore it is advisable to try the therapy also in other cases. The conditions of the study are exactly reported. The influence on the clinic of the disease and on the laboratory data obtained in many controls will be published later, because the statistical analysis needs some more time.

Asunto(s)

Flavonoides/uso terapéutico , Cirrosis Hepática/tratamiento farmacológico , Silimarina/uso terapéutico , Ensayos Clínicos como Asunto , Método Doble Ciego , Humanos , Cirrosis Hepática/mortalidad , Cirrosis Hepática Alcohólica/tratamiento farmacológico , Cirrosis Hepática Alcohólica/mortalidad , Distribución Aleatoria